SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-19-000027
Filing Date
2019-05-07
Accepted
2019-05-07 16:08:53
Documents
72
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q haloq12019-10q.htm 10-Q 1072068
2 EXHIBIT 31.1 ex311q12019.htm EX-31.1 17197
3 EXHIBIT 31.2 ex312q12019.htm EX-31.2 17245
4 EXHIBIT 32 ex32q12019.htm EX-32 19992
11 slide1a88.jpg GRAPHIC 297946
12 slide2a71.jpg GRAPHIC 352209
13 slide3a76.jpg GRAPHIC 260845
  Complete submission text file 0001159036-19-000027.txt   7154445

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT halo-20190331.xml EX-101.INS 1293892
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20190331.xsd EX-101.SCH 43894
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20190331_cal.xml EX-101.CAL 84904
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20190331_def.xml EX-101.DEF 171872
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20190331_lab.xml EX-101.LAB 544377
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20190331_pre.xml EX-101.PRE 318322
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 19803170
SIC: 2836 Biological Products, (No Diagnostic Substances)